Organization · Venture Capital
Device of Tomorrow Capital
Device of Tomorrow Capital is an early-stage investment fund based in the United States, focusing on breakthrough innovations in medical technology. The fund aims to support entrepreneurs who are transforming healthcare through advanced technologies.
Overview
What Device of Tomorrow Capital does
What Device of Tomorrow Capital is
Device of Tomorrow Capital is an early-stage investment fund based in the United States, focusing on breakthrough innovations in medical technology. The fund aims to support entrepreneurs who are transforming healthcare through advanced technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Device of Tomorrow Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Device of Tomorrow Capital as a funder
Investment thesis
Invests in breakthrough medical technology innovations with major market potential and robust clinical data. Focus on solving significant healthcare challenges with technology differentiation.
Focus narrative
Device of Tomorrow Capital invests in breakthrough innovations within the medical technology field, particularly in the United States. Their areas of interest include artificial intelligence, robotics, and biotechnology, among other advanced technologies that are reshaping healthcare.
Value beyond capital
Device of Tomorrow Capital provides strategic guidance and support to its portfolio companies, leveraging industry expertise and connections to help entrepreneurs navigate the complexities of the healthcare market.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- AI · Biotech · Healthcare · Medical Devices · Robotics
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Carlsmed: The first company using AI and 3D printing for customized treatment plans for adult spinal deformities. Telesair: Developing scalable, AI-enabled blood tests for early cancer detection. Andromeda: Focused on a radiotherapy solution that reduces costs and side effects. WearLinq: Offers FDA-cleared endovascular therapy navigation technology. Paloma: A wireless, catheter-free urodynamic monitoring system. iCardio.AI: An AI diagnostic tool for early detection of Alzheimer's Disease and related disorders. Leo Cancer Care: Innovating in personalized healthcare with advanced surgical planning solutions. Aureka Biotechnologies: Developing a therapeutic discovery platform.
Common questions
What to know about Device of Tomorrow Capital
Upseed classifies Device of Tomorrow Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.